# US 2023/0135347 A1 · Hydrogels with biodegradable crosslinking

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0135347 A1
- Document ID: US20230135347A1
- Status: Published application
- Kind: A1
- Application number: 17/930,381
- Filed: 2022-09-07
- Published: 2023-05-04
- Earliest claimed: 2011-09-07
- Assignees: ProLynx LLC
- Applicants: ProLynx LLC
- Inventors: Gary W. ASHLEY; Daniel V. SANTI; Jeffrey C. HENISE
- Web page: https://patentgrep.com/patent/US20230135347A1

## CPC

- A61K 47/34: Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers (A61K47/10 takes precedence)
- A61K 9/06: Ointments; Bases therefor; {Other semi-solid forms, e.g. creams, sticks, gels (composition of ointments, creams or gels A61K47/00)}
- A61K 47/30: Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K 47/50: the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K 47/60: the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
- A61K 47/61: the organic macromolecular compound being a polysaccharide or a derivative thereof
- A61K 47/6903: {the form being semi-solid, e.g. an ointment, a gel, a hydrogel or a solidifying gel}
- A61L 15/26: Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof {(A61L15/225 takes precedence)}
- A61L 15/44: Medicaments
- A61L 15/60: Liquid-swellable gel-forming materials, e.g. super-absorbents
- A61L 15/64: specially adapted to be resorbable inside the body
- A61L 27/18: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- A61L 27/52: Hydrogels or hydrocolloids
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- A61L 27/58: Materials at least partially resorbable by the body
- C07C 271/08: having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C 317/18: with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
- C08J 3/075: Macromolecular gels
- C09B 23/0025: {the substituent being bound through an oxygen atom}
- C09B 23/0033: {the substituent being bound through a sulfur atom}
- C09B 23/0066: {the polymethine chain being part of a carbocyclic ring,(e.g. benzene, naphtalene, cyclohexene, cyclobutenene-quadratic acid)}
- C09B 23/0075: {the polymethine chain being part of an heterocyclic ring}
- G02F 1/3611: {containing Nitrogen}
- G02F 1/3612: {Heterocycles having N as heteroatom}
- G02F 1/3614: {Heterocycles having S as heteroatom}
- G02F 1/3615: {containing polymers}
- C08G 2650/30: branched
- C08J 2300/16: Biodegradable polymers
- C08J 2305/08: Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
- C08J 2371/02: Polyalkylene oxides
- Y10T 428/261: In terms of molecular thickness or light wave length
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C08J: WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H (working, e.g. shaping, of plastics B29)
- C09B: ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES {, e.g. PIGMENTS}; MORDANTS; LAKES (fermentation or enzyme using processes to synthesise a desired chemical compound C12P)
- G02F: OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- C08G: MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

## Abstract

Hydrogels that degrade under appropriate conditions of pH and temperature by virtue of crosslinking compounds that cleave through an elimination reaction are described. The hydrogels may be used for delivery of various agents, such as pharmaceuticals.

## Claims

### Claim 1

A hydrogel that is biodegradable under physiological conditions, wherein the hydrogel comprises one or more hyaluronic acid polymers crosslinked by a linker that decomposes by a beta elimination reaction,
wherein said linker is of Formula (1):
wherein for each linker of formula (1):
m of formula (1) is 0 or 1;
X of formula (1) is
wherein
T* is O, S, or NR6, wherein R6 is H, optionally substituted alkyl, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted arylalkyl, or optionally substituted heteroarylalkyl;
z is 1-6;
Y is (OCH2CH2)p, wherein p is 1-100; and
Z2 is a first functional group that is coupled to a first cognate functional group on a hyaluronic acid polymer;
one of R1, R2, or R5 comprises a second functional group that is coupled to a second cognate functional group on a hyaluronic acid polymer,
wherein each said first functional group and said second functional group comprises N3, NH2, NH-CO2tBu, SH, StBu, maleimide, CO2H, CO2tBu, 1,3-diene, cyclopentadiene, furan, alkyne, cyclooctyne, acrylate, or acrylamide;
with the proviso that:
(1) when one of R5 of formula (1) comprises a second functional group that is coupled to a second cognate group of a hyaluronic acid polymer, the remaining R5 of formula (1) is H, optionally substituted alkyl, optionally substituted alkenylalkyl, optionally substituted alkynylalkyl, (OCH2CH2)p O-alkyl wherein p=1-1000, optionally substituted aryl, optionally substituted arylalkyl, optionally substituted heteroaryl, or optionally substituted heteroarylalkyl: and
(a) R1 and R2 of formula (1) are independently CN, NO2, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted alkenyl, optionally substituted alkynyl, COR3, SOR3, SO2R3, or SR4;
(b) R1 and R2 of formula (1) may be joined to form a 3-8 membered ring;
(c) R1 of formula (1) is CN, NO2, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted alkenyl, optionally substituted alkynyl, COR3, SOR3, SO2R3, or SR4; and R2 of formula (1) is H, optionally substituted alkyl, optionally substituted arylalkyl, or optionally substituted heteroarylalkyl; or
(d) R2 of formula (1) is CN, NO2, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted alkenyl, optionally substituted alkynyl, COR3, SOR3, SO2R3, or SR4; and R1 of formula (1) is H, optionally substituted alkyl, optionally substituted arylalkyl, or optionally substituted heteroarylalkyl; or
(2) when R1 of formula (1) comprises a second functional group that is coupled to a second cognate group of a hyaluronic acid polymer: R2 of formula (1) is CN, NO2, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted alkenyl, optionally substituted alkynyl, COR3, SOR3, SO2R3, or SR4; and each R5 of formula (1) is independently H, optionally substituted alkyl, optionally substituted alkenylalkyl, optionally substituted alkynylalkyl, (OCH2CH2)p O-alkyl wherein p=1-1000, optionally substituted aryl, optionally substituted arylalkyl, optionally substituted heteroaryl, or optionally substituted heteroarylalkyl; or
(3) when R2 of formula (1) comprises a second functional group that is coupled to a second cognate group of a hyaluronic acid polymer: R1 of formula (1) is CN, NO2, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted alkenyl, optionally substituted alkynyl, COR3, SOR3, SO2R3, or SR4; and each R5 of formula (1) is independently H, optionally substituted alkyl, optionally substituted alkenylalkyl, optionally substituted alkynylalkyl, (OCH2CH2)p O-alkyl wherein p=1-1000, optionally substituted aryl, optionally substituted arylalkyl, optionally substituted heteroaryl, or optionally substituted heteroarylalkyl;
wherein
R3 is selected from the group consisting of (i) H; (ii) optionally substituted alkyl; (iii) optionally substituted aryl; (iv) optionally substituted arylalkyl; (v) optionally substituted heteroaryl; (vi) optionally substituted heteroarylalkyl; (vii) OR9; and (viii) NR92;
R4 is selected from the group consisting of (i) optionally substituted alkyl; (ii) optionally substituted aryl; (iii) optionally substituted arylalkyl; (iv) optionally substituted heteroaryl; and (v) optionally substituted heteroarylalkyl; and
each R9 is independently H or optionally substituted alkyl, or both R9 groups taken together with the nitrogen to which they are attached form a heterocyclic ring.

### Claim 2 (depends on 1)

The biodegradable hydrogel of claim 1, wherein each said first functional group and said second functional group comprises N3.

### Claim 3 (depends on 1)

The biodegradable hydrogel of claim 1, wherein in Formula (1):
m is 0.

### Claim 4 (depends on 1)

The biodegradable hydrogel of claim 1, wherein in Formula (1):
R2 is H;
one of R5 is H; and
the other R5 is (CH2)nZ, wherein n is 1-6 and Z includes said second functional group.

### Claim 5 (depends on 4)

The biodegradable hydrogel of claim 4, wherein n is 5.

### Claim 6 (depends on 1)

The biodegradable hydrogel of claim 1, wherein in Formula (1):
R1 is CN or SO2R3.

### Claim 7 (depends on 6)

The biodegradable hydrogel of claim 6, wherein in Formula (1):
R1 is SO2Ph.

### Claim 8 (depends on 1)

The biodegradable hydrogel of claim 1, wherein in X of Formula (1):
T* is O, S, or NR6, wherein R6 is H;
z is 1-6; and
Y is (OCH2CH2)p, wherein p is 1-100.

### Claim 9 (depends on 1)

The biodegradable hydrogel of claim 1, wherein the coupling of the first functional group with the first cognate group and the coupling of the second functional group with the second cognate group each comprises a product of:
a reaction of N3 with acetylene, cyclooctyne, or maleimide;
a reaction of SH with maleimide, acrylate, acrylamide, vinylsulfone, vinylsulfonamide, or halocarbonyl;
a reaction of NH2 with carboxylic acid or activated carboxylic acid; or
a reaction of maleimide with 1,3-diene, cyclopentadiene, or furan.

### Claim 10 (depends on 1)

The biodegradable hydrogel of claim 1, wherein the coupling of the first functional group with the first cognate group and the coupling of the second functional group with the second cognate group each comprises a product of a reaction of N3 with cyclooctyne.

### Claim 11 (depends on 1)

The biodegradable hydrogel of claim 1, wherein each first functional group and second functional group comprises N3.

### Claim 12 (depends on 1)

The biodegradable hydrogel of claim 1, wherein:
each first cognate functional group and second cognate functional group of the hyaluronic acid polymer comprises cyclooctyne;
m of formula (1) is 0;
X of formula (1) is
wherein
T* is NR6, wherein R6 is H;
z is 2;
Y is (OCH2CH2)3; and
Z2 is the first functional group and is N3;
R1 of formula (1) is SO2Ph;
R2 of formula (1) is H;
one of R5 of formula (1) is H; and
the other R5 of formula (1) is (CH2)5Z, wherein Z is the second functional group and is N3.
